Fisher Asset Management LLC lessened its stake in shares of STERIS plc (NYSE:STE – Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,009 shares of the medical equipment provider’s stock after selling 170 shares during the period. Fisher Asset Management LLC’s holdings in STERIS were worth $208,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of STE. Ashton Thomas Securities LLC purchased a new position in shares of STERIS in the third quarter valued at about $25,000. Human Investing LLC bought a new stake in STERIS during the fourth quarter worth approximately $31,000. Central Pacific Bank Trust Division grew its stake in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. Manchester Capital Management LLC grew its stake in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the last quarter. Finally, Quarry LP bought a new position in shares of STERIS during the third quarter valued at approximately $67,000. Institutional investors own 94.69% of the company’s stock.
Wall Street Analyst Weigh In
STE has been the topic of several research analyst reports. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $258.75.
STERIS Price Performance
Shares of STERIS stock opened at $233.02 on Friday. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a twelve month low of $197.82 and a twelve month high of $248.24. The business has a 50-day moving average price of $216.96 and a 200 day moving average price of $222.78. The firm has a market cap of $22.89 billion, a PE ratio of 49.47 and a beta of 0.92.
STERIS (NYSE:STE – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Sell-side analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.
STERIS Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
See Also
- Five stocks we like better than STERIS
- The Significance of Brokerage Rankings in Stock Selection
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- Pros And Cons Of Monthly Dividend Stocks
- 3 Stocks to Buy While Others Stay on the Sidelines
- Short Selling: How to Short a Stock
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.